Skip to main content
Equibles
TNDM logo

TNDM · Tandem Diabetes Care Inc · Earnings Call Transcripts & Audio

Track TNDM — free

Use TNDM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TNDM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$16.31 -0.26 (-1.57%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.09B
Shares
69.58M
Volume · Sep 30 2.2M Avg daily vol (3M) 1.93M

Tandem Diabetes Care Inc Earnings Call Transcripts

Quarterly earnings calls for Tandem Diabetes Care Inc (TNDM), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲13.9% $204.55M −$48.97M '22 Q3 22-11-02 ▲5% $220.50M −$15.85M '22 Q4 23-01-10 ▼3.7% $169.38M −$123.87M '23 Q1 23-05-03 ▼2.2% $195.92M −$35.77M '23 Q2 23-08-03 ▼9.3% $185.62M −$32.96M '23 Q3 23-11-01 ▼10.8% $196.80M −$30.00M '23 Q4 24-02-21 ▲13.2% $191.67M −$42.72M '24 Q1 24-05-02 ▲13.3% $221.91M −$30.81M '24 Q2 24-08-01 ▲31.4% $243.97M −$23.25M '24 Q3 24-11-06 ▲43.6% $282.65M $755,000 '24 Q4 25-02-26 ▲22.3% $234.42M −$130.56M '25 Q1 25-04-30 ▲8.5% $240.68M −$52.40M '25 Q2 25-08-06 ▲2.2% $249.25M −$21.16M '25 Q3 25-11-06 ▲2.7% $290.38M −$589,000 '25 Q4 26-02-19 ▲5.5% $247.22M −$20.39M '26 Q1 26-05-07 LATEST ▲5.8% $254.56M −$21.17M '26 Q2 26-08-06
Conference
Investor event
2026-08-11
Tandem Diabetes Care Inc (TNDM) August 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-06
Tandem Diabetes Care Inc (TNDM) Q2 2026 Earnings Call Transcript
Confident tone Pharmacy / PAYGO transition Mobi tubeless launch International expansion
Revenue
$254.56M
▲ 5.8% YoY
Diluted EPS
$-0.31
Gross margin
56.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Tandem Diabetes Care Inc (TNDM) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Tandem Diabetes Care Inc (TNDM) Q1 2026 Earnings Call Transcript
Confident tone Pharmacy/PayGo transition New product launches and pipeline International expansion / direct operations
Revenue
$247.22M
▲ 5.5% YoY
Diluted EPS
$-0.30
Gross margin
55.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-19
Tandem Diabetes Care Inc (TNDM) Q4 2025 Earnings Call Transcript
Revenue
$290.38M
▲ 2.7% YoY
Diluted EPS
$-0.01
▼ 200% YoY
Gross margin
57.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-06
Tandem Diabetes Care Inc (TNDM) Q3 2025 Earnings Call Transcript
Confident tone Pharmacy reimbursement strategy Profitability and margin improvement Product innovation and pipeline
Revenue
$249.25M
▲ 2.2% YoY
Diluted EPS
$-0.31
Gross margin
53.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Tandem Diabetes Care Inc (TNDM) Q2 2025 Earnings Call Transcript
Positive tone Tandem Mobi product momentum Type 2 diabetes expansion U.S. commercial performance and pump shipments
Revenue
$240.68M
▲ 8.5% YoY
Diluted EPS
$-0.78
Gross margin
52.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-30
Tandem Diabetes Care Inc (TNDM) Q1 2025 Earnings Call Transcript
Confident tone Gross Margin Expansion Path Pharmacy Channel Access International Growth and Direct Sales Transition
Revenue
$234.42M
▲ 22.3% YoY
Diluted EPS
$-1.97
Gross margin
50.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-26
Tandem Diabetes Care Inc (TNDM) Q4 2024 Earnings Call Transcript
Confident tone Tandem Mobi pump platform Type 2 diabetes label expansion Control-IQ+ algorithm launch
Revenue
$282.65M
▲ 43.6% YoY
Diluted EPS
$0.01
Gross margin
55.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-06
Tandem Diabetes Care Inc (TNDM) Q3 2024 Earnings Call Transcript
Confident tone Type 2 diabetes market opportunity Tandem Mobi launch and adoption Renewals momentum
Revenue
$243.97M
▲ 31.4% YoY
Diluted EPS
$-0.35
Gross margin
51.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
Tandem Diabetes Care Inc (TNDM) Q2 2024 Earnings Call Transcript
Confident tone Tandem Mobi launch Control-IQ algorithm New sensor integrations / CGM partnerships
Revenue
$221.91M
▲ 13.3% YoY
Diluted EPS
$-0.47
Gross margin
50.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Tandem Diabetes Care Inc (TNDM) Q1 2024 Earnings Call Transcript
Confident tone Mobi product launch Guidance philosophy and conservatism Pharmacy channel opportunity
Revenue
$191.67M
▲ 13.2% YoY
Diluted EPS
$-0.65
Gross margin
49.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-21
Tandem Diabetes Care Inc (TNDM) Q4 2023 Earnings Call Transcript
Confident tone Tandem Mobi launch Renewals and customer base growth International expansion and OUS challenges
Revenue
$196.80M
▼ 10.8% YoY
Diluted EPS
$-0.46
Gross margin
47.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Tandem Diabetes Care Inc (TNDM) Q3 2023 Earnings Call Transcript
Revenue
$185.62M
▼ 9.3% YoY
Diluted EPS
$-0.51
Gross margin
48.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Tandem Diabetes Care Inc (TNDM) Q2 2023 Earnings Call Transcript
Revenue
$195.92M
▼ 2.2% YoY
Diluted EPS
$-0.55
Gross margin
51.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Tandem Diabetes Care Inc (TNDM) Q1 2023 Earnings Call Transcript
Revenue
$169.38M
▼ 3.7% YoY
Diluted EPS
$-1.92
Gross margin
48.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-01-10
Tandem Diabetes Care Inc (TNDM) Q4 2022 Earnings Call Transcript
Revenue
$220.50M
▲ 5% YoY
Diluted EPS
$-0.25
▼ 256.2% YoY
Gross margin
52.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Tandem Diabetes Care Inc (TNDM) Q3 2022 Earnings Call Transcript
Revenue
$204.55M
▲ 13.9% YoY
Diluted EPS
$-0.76
▼ 944.4% YoY
Gross margin
51.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
Tandem Diabetes Care Inc (TNDM) Q2 2022 Earnings Call Transcript
Revenue
$200.26M
▲ 16.3% YoY
Diluted EPS
$-0.24
▼ 500% YoY
Gross margin
50.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Tandem Diabetes Care Inc (TNDM) Q1 2022 Earnings Call Transcript
Revenue
$175.91M
▲ 24.7% YoY
Diluted EPS
$-0.23
Gross margin
51.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-22
Tandem Diabetes Care Inc (TNDM) Q4 2021 Earnings Call Transcript
Revenue
$210.00M
▲ 24.9% YoY
Diluted EPS
$0.16
▼ 27.3% YoY
Gross margin
54.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-03
Tandem Diabetes Care Inc (TNDM) Q3 2021 Earnings Call Transcript
Revenue
$179.63M
▲ 45.3% YoY
Diluted EPS
$0.09
Gross margin
53.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Tandem Diabetes Care Inc (TNDM) Q2 2021 Earnings Call Transcript
Revenue
$172.14M
▲ 57.6% YoY
Diluted EPS
$0.06
Gross margin
53.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Tandem Diabetes Care Inc (TNDM) Q1 2021 Earnings Call Transcript
Revenue
$141.04M
▲ 44% YoY
Diluted EPS
$-0.08
Gross margin
52.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Tandem Diabetes Care Inc (TNDM) Q4 2020 Earnings Call Transcript
Revenue
$168.06M
▲ 55% YoY
Diluted EPS
$0.22
▲ 450% YoY
Gross margin
53.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Tandem Diabetes Care Inc (TNDM) Q3 2020 Earnings Call Transcript
Revenue
$123.60M
▲ 30.6% YoY
Diluted EPS
$-0.15
Gross margin
52.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Tandem Diabetes Care Inc (TNDM) Q2 2020 Earnings Call Transcript
Revenue
$109.24M
▲ 17.1% YoY
Diluted EPS
$-0.45
Gross margin
49.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-30
Tandem Diabetes Care Inc (TNDM) Q1 2020 Earnings Call Transcript
Revenue
$97.93M
▲ 48.4% YoY
Diluted EPS
$-0.25
Gross margin
51.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-24
Tandem Diabetes Care Inc (TNDM) Q4 2019 Earnings Call
Revenue
$108.40M
▲ 42.3% YoY
Diluted EPS
$0.04
▲ 100% YoY
Gross margin
55.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–29 of 29 earnings calls
Key facts CIK 1438133 CUSIP 875372203 13F (30d) 14 filings 8 filers Visit website Investor relations